Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Breast Cancer Intervention Study II
NCT00078832Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Sep 2003
- Primary completion
- Dec 2013
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 14
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing anastrozole with placebo (2 arms). Primary endpoint: Development of histologically confirmed breast cancer, both invasive and non-invasive at 5 years. Started Sep 2003; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00078832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078832.